Evaluation of the efficacy of tramadol in the prevention of post spinal anaesthesia shivering in caesarean deliveries

Samenvatting

Background: Post-spinal anesthesia shivering is a common complication during cesarean deliveries, affecting maternal comfort and potentially impacting neonatal outcomes. Various preventive measures exist, but their efficacy remains uncertain, prompting exploration of alternative strategies such as tramadol.
Objective: This study aims to evaluate the effectiveness of tramadol in preventing post-spinal anesthesia shivering during cesarean deliveries compared to standard methods.
Methods: A randomized controlled trial was conducted involving 150 of parturients scheduled for elective cesarean sections under spinal anesthesia. Participants were randomized into two groups: tramadol and placebo. Shivering incidence, severity, and duration were assessed using a standardized scale. Maternal and neonatal parameters were secondary outcome measures. Statistical analyses were conducted to compare outcomes between groups.
Results: Tramadol significantly reduced post-spinal anesthesia shivering incidence (12% vs. 30% placebo) and severity scores (0.8 vs. 1.5 immediately post-delivery). Maternal vital signs remained stable. Neonatal Apgar scores (1 & 5 mins) showed no significant differences, indicating tramadol's efficacy without adverse neonatal effects.
Conclusion: Tramadol showed efficacy in reducing post-spinal anesthesia shivering during cesarean deliveries without significant adverse effects on mothers or newborns. These findings suggest tramadol could serve as a potential preventive measure in this clinical setting, although further studies are warranted to validate its long-term safety and cost-effectiveness.